Demant


As expected, a new product launched

01/12/20 -"Demant has launched a new product – Oticon More comes with an industry-first in-built Deep Neural Network (deep/ machine learning) which improves audiology performance. This is a multi-brand launch, ..."

Pages
57
Language
English
Published on
01/12/20
You may also be interested by these reports :
05/01/21
Korian has concluded a long-term partnership with BNP Paribas Cardif and EDF Invest to support the implementation of its Asset Smart strategy.

11/12/20
A recovery was visible in Q4 19/20 on the back of pent-up demand for consumables and implants, particularly in the Asia-Pacific region. Although the ...

10/12/20
Thanks to better-than-expected demand for COVID-19 products and improved sales momentum for non-COVID-19 solutions, Qiagen has upgraded its FY20 ...

09/12/20
We have made up our mind and believe Varian will not be a mere addition: the acquisition has the potential to play cancer treatment differently. We ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO